Anonymous wrote:Anonymous wrote:Research and development costs are huge. We have to pay for innovation.
If you stick to old drugs off patent, they are cheap.
That does not explain why Americans pay a different price from Germans or French. They buy the same drugs from the same companies.
Anonymous wrote:Research and development costs are huge. We have to pay for innovation.
If you stick to old drugs off patent, they are cheap.
Anonymous wrote:Anonymous wrote:Anonymous wrote:Research and development costs are huge. We have to pay for innovation.
If you stick to old drugs off patent, they are cheap.
Fake News. American drug companies spend far more in marketing then they do in R&D. Next PhRMA argument?
Then don't take the drugs. No one forces them upon you. Stick to the $2 list. It works for many things.
Anonymous wrote:It’s all those R&D costs!


Anonymous wrote:Anonymous wrote:Research and development costs are huge. We have to pay for innovation.
If you stick to old drugs off patent, they are cheap.
Fake News. American drug companies spend far more in marketing then they do in R&D. Next PhRMA argument?
Anonymous wrote:Research and development costs are huge. We have to pay for innovation.
If you stick to old drugs off patent, they are cheap.
Anonymous wrote:Anonymous wrote:Research and development costs are huge. We have to pay for innovation.
If you stick to old drugs off patent, they are cheap.
LIES. Pharma spends 2x as much on marketing as R&D. Plus, their R&D is tax deductible, their "R&D" often relies on "free" research generated from government grants.
It's just greedy assholes buying politicians in search of endless risk-free profits. That's it.
Anonymous wrote:Research and development costs are huge. We have to pay for innovation.
If you stick to old drugs off patent, they are cheap.